asthma by dr sarma

88
Dr.Sarma@works 1 LIFE TIME HAPPINESS

Upload: surbhi-joshi

Post on 01-May-2017

234 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Asthma by Dr Sarma

Dr.Sarma@works 1

LIFE TIME HAPPINESS

Page 2: Asthma by Dr Sarma

Dr.Sarma@works 2

When you can't breathe, nothing else

matters®American Lung

Association

Page 3: Asthma by Dr Sarma

3 Dr.Sarma@works

CD format of today’s presentation is ready

1. Asthma, COPD and Basics of Spirometry

In addition it, also contains

2. ECG workshop presented earlier

3. Guidelines on Hypertension treatment

This can be used in Computer & DVD player

Important Announcement

Page 4: Asthma by Dr Sarma

Dr.Sarma@works 4

1. ACCP www.chestnet.org2. ATS www.thoracic.org3. BTS www.brit-thoracic.org.uk4. COPD profess.

www.copdprofessional.com5. GOLD www.goldcopd.com6. NICE www.nice.uk.org7. Chest Net www.chestnet.net8. CDC www.cdc.nih.gov9. NAEPP www.naepp.nhlbi.org10.COPD Rapid series by ELSEVIER

COPD and Asthma Resources

Page 5: Asthma by Dr Sarma

Dr.Sarma@works 5

CHRONIC LUNG DISEASES

Pulmonary Tuberculosis Restrictive lung diseases Suppurative lung disease Obstructive lung diseases

– Bronchial Asthma– Chronic bronchitis– Emphysema and

Their differentiations

Page 6: Asthma by Dr Sarma

Dr.Sarma@works 6

AN OVERVIEW - GINAMANAGEMENT GUIDE LINES

Dr. Sarma.R.V.S.N., M.D., M.Sc (Canada)

Consultant Physician and chest specialist

# 5, Jayanagar, Tiruvallur 602 001+ 91 9894- 60593, (4116) 260593

ASTHMA

Page 7: Asthma by Dr Sarma

Dr.Sarma@works 7

WHAT IS ASTHMA ?

Primarily it is an allergic inflam-matory disorder of the airways

Infiltration of mast cells, eosinophils and lymphocytes

Secondary broncho-constriction Airway hyper-responsiveness Recurrent episodes of wheezing,

coughing and shortness of breath Airflow limitation is variable and

often reversible and wide spread

Page 8: Asthma by Dr Sarma

Dr.Sarma@works 8

BURDEN OF ILLNESS

15- 20 million asthmatics in India. A recent study conducted in Delhi

established asthma prevalence to be 12% in school children.

Significant cause of school/work absence. Health care expenditures very high. Morbidity and mortality are on the rise.

Page 9: Asthma by Dr Sarma

Dr.Sarma@works 9

THE HUGE GAP

Patients are not detected Do not seek medical attention No access to health service Stigma associated with the label Broken marriages, alliances Missed diagnosis (bronchitis, LRTI)

Page 10: Asthma by Dr Sarma

MECHANISM OF ASTHMA

INFLAMMATIONINFLAMMATION

Risk Factors (for development of asthma)

AirwayHyper responsiveness Airflow

Limitation

Symptoms- (shortness of breath, cough, wheeze)Risk Factors

(for exacerbations)

Page 11: Asthma by Dr Sarma

Dr.Sarma@works 11

ASTHMA : PATHOLOGY

Page 12: Asthma by Dr Sarma

Dr.Sarma@works 12

RISK FACTORS FOR ASTHMA

Predisposing Factors Atopy (↑ IgE)

Causal Factors Indoor Allergens

– Domestic mites– Animal Allergens– Cockroach Allergens– Fungi moulds

Outdoor Allergens– Pollens– Fungi, RSV

Occupational Sensitizers

Contributing Factors Respiratory infections Small size at birth Diet Air pollution

– Outdoor pollutants– Indoor pollutants

Smoking– Passive Smoking– Active Smoking

Page 13: Asthma by Dr Sarma

Dr.Sarma@works 13

HOUSE DUST MITE

Use bedding encasementsUse bedding encasements Wash bed linens weeklyWash bed linens weekly Avoid down fillingsAvoid down fillings Limit stuffed toys to thoseLimit stuffed toys to those that can be washedthat can be washed Reduce humidity levelReduce humidity level

Page 14: Asthma by Dr Sarma

Dr.Sarma@works 14

COCKROACHES

Remove as many Remove as many water and food water and food sources as sources as possible to avoid possible to avoid cockroaches.cockroaches.

Page 15: Asthma by Dr Sarma

Dr.Sarma@works 15

PETS

People allergic to pets should not People allergic to pets should not have them in the house.have them in the house. At a minimum, do not allow pets in At a minimum, do not allow pets in the bedroom.the bedroom.

Page 16: Asthma by Dr Sarma

Dr.Sarma@works 16

MOLDS - FUNGUS

Eliminating mold may help control asthma exacerbations.Eliminating mold may help control asthma exacerbations.

Page 17: Asthma by Dr Sarma

Dr.Sarma@works 17

History and patterns of symptoms Physical examination Measurements of lung function

– Peak flow meter– Spirometry

DIAGNOSIS OF ASTHMA

Page 18: Asthma by Dr Sarma

Dr.Sarma@works 18

PATIENT HISTORY

Has the patient had an attack or recurrent episodes of wheezing?

Does the patient have a troublesome cough, worse particularly at night, or on awakening?

Does the patient cough after physical activity (eg. Playing)?

Does the patient have breathing problems during a particular season (or change of season)?

Page 19: Asthma by Dr Sarma

Dr.Sarma@works 19

MAIN SYMPTOM CLUES

Do the patient’s colds ‘go to the chest’ or take more than 10 days to resolve?

Does the patient use any medication ? (e.g. bronchodilator) when symptoms occur ? - Is there a (relief) response?

If the patient answers “YES” to any of the above questions, suspect asthma.

Remember, the commonest cause of persistent cough is asthma

Page 20: Asthma by Dr Sarma

Dr.Sarma@works 20

PHYSICAL EXAM

Wheeze -Usually heard without a stethoscope

Dyspnoea -Rhonchi heard with a stethoscopeUse of accessory muscles

Remember -Absence of symptoms at the time of examination does not exclude the diagnosis of asthma

Page 21: Asthma by Dr Sarma

Dr.Sarma@works 21

Hyper-expansion of the thorax Increased nasal secretions or

nasal polyps Atopic dermatitis, eczema, or

other allergic skin conditions

PHYSICAL EXAM

Page 22: Asthma by Dr Sarma

Dr.Sarma@works 22

SCREENING TEST

Diagnosis of asthma can be suspected by demonstrating the presence of airway obstruction using Peak flow meter.

Peak Flow Meter is a basic tool in a GPs office

PEFR amplitude ?

Page 23: Asthma by Dr Sarma

Dr.Sarma@works 23

DIAGNOSTIC TEST

Diagnosis of asthma can be confirmed by demonstrating the presence of reversible airway obstruction using Spirometry.

Page 24: Asthma by Dr Sarma

Dr.Sarma@works 24

SPIROMETRY

Let me now take you through to the understanding of the basics of spirometry

Page 25: Asthma by Dr Sarma

Dr.Sarma@works 25

SPIROMETRY

Basic Issues

Page 26: Asthma by Dr Sarma

Dr.Sarma@works 26

LUNG FUNCTION TESTS

Tests of VentilationTests of DiffusionTests of PerfusionTests for V-P

Mismatch

Page 27: Asthma by Dr Sarma

Dr.Sarma@works 27

LUNG FUNCTION TESTS

Tests of VentilationTests of DiffusionTests of PerfusionTests for V-P

Mismatch

Page 28: Asthma by Dr Sarma

Dr.Sarma@works 28

VENTILATION

Peak Expiratory Flow Rate– Simple, Peak flow meter is used

Flow volume loop , Flow time curve– Detailed, Spirometry is used

Page 29: Asthma by Dr Sarma

Dr.Sarma@works 29

PEAK FLOW METER

Diagnosis of ASTHMA or COPD can beconfirmed by demonstrating the presenceof airway obstruction using Spirometry.

Page 30: Asthma by Dr Sarma

Dr.Sarma@works 30

PEFR - Pros and Cons

Advantages– With in 1 to 2 minutes,– Inexpensive (meter costs less than Rs.1000)– Simple, useful for frequent follow up use

Disadvantages– Very much effort dependent– Insensitive to small changes– Small airways cannot be assessed– Large inter & intra subject variation;↓accurate

Page 31: Asthma by Dr Sarma

Dr.Sarma@works 31

SPIROMETRY

Page 32: Asthma by Dr Sarma

Dr.Sarma@works 32

Spirometry - Pros and Cons

Advantages– Evaluates smaller as well as larger airways– Relatively easy to use and maintain– Reversibility can be tested with IBD and steroids– Diagnostic as well as management assessments

Disadvantages– Cost about 50,000 + computer and printer– Takes time to perform – 10 to 15 minutes– Requires training – at least one day course

Page 33: Asthma by Dr Sarma

Dr.Sarma@works 33

Spirometry Maneuver

In single breath testA few normal tidal respirationsThen deeeeep inspirationMomentary breath holdingVery forced and fast expiration

– As hard and as fast as he/she can blow outThen deep, quick and full inspirationRepeat at least 3 times – take the best

Page 34: Asthma by Dr Sarma

Dr.Sarma@works 34

Spirometry Results

FVC Forced Vital CapacityFEV1 Forced Expiratory

Volume in the first second FEV1÷FVC Ratio of the above twoPEFR Peak Expiratory Flow

RateFET Forced Expiratory Time

Page 35: Asthma by Dr Sarma

Dr.Sarma@works 35

Spirometry Normal Values

1. There are no fixed ‘Normal’ values2. Dependent on age, sex, ht, wt, ethnicity3. Observed value expressed as predicted value %

FVC Normal if > 80% of predicted FEV1 Normal if > 80% of predicted FEV1/FVC At least 75% PEFR Normal if > 80% of predicted FET Less than 4 seconds

Page 36: Asthma by Dr Sarma

Dr.Sarma@works 36

Obstructive v/s Restrictive

Parameter Normal Obstructive Restrictive

Problem ‘Air out’ and ‘Air in’ normal

Unable to get‘Air out’

Unable to get‘Air in’

FVC 80 % of pred Normal or ↓ ↓,↓TLC

FEV1 80 % of pred ↓-80% or less Normal

FEV1 ÷ FVC Min. of 75% ↓-70% or less Normal or ↑

PEFR 80 % of pred ↓-80% or less Normal

FET in sec Less than 4 Prolonged > 4 Normal - < 4

Page 37: Asthma by Dr Sarma

Dr.Sarma@works 37

Flow-Volume, Volume-Time Graphs

Page 38: Asthma by Dr Sarma

Dr.Sarma@works 38

Normal Flow-Volume Loop

Page 39: Asthma by Dr Sarma

Dr.Sarma@works 39

Flow-Volume Loop in disease

Mild reversible obstruc Severe irreversible obstr Severe restrictive dis

ASTHMA COPD ILD

Page 40: Asthma by Dr Sarma

Dr.Sarma@works 40

Office Spirometry

Page 41: Asthma by Dr Sarma

Dr.Sarma@works 41

BACK TO ASTMA

Now, with this understanding of spirometry, let us proceed to look at the management of Asthma

Page 42: Asthma by Dr Sarma

Dr.Sarma@works 42

CLASSIFICATION OF SEVERITY

STEP 4Severe

PersistentSTEP 3

Moderate Persistent

STEP 2Mild

Persistent

STEP 1Intermittent

The presence of one of the features of severity is sufficient to place a patient in that category.

Global Initiative for Asthma (GINA) WHO/NHLBI, 2002

Symptoms NighttimeSymptoms FEV1

CLASSIFY SEVERITYClinical Features Before Treatment

ContinuousLimited physical activity

DailyUse 2-agonist dailyAttacks affect activity>1 time a week but <1 time a day< 1 time a weekAsymptomatic and normal PEF between attacks

Frequent

>1 time week

>2 times a month

<2 times a month

<60% predictedVariability >30%

>60%-<80% predictedVariability >30%

>80% predictedVariability 20-30%

>80% predictedVariability <20%

Page 43: Asthma by Dr Sarma

Dr.Sarma@works 43

GOALS IN ASTHMA CONTROL

Achieve and maintain control of symptoms Prevent asthma episodes or attacks Minimal use of reliever medication No emergency visits to doctors or hospitals Maintain normal activity levels, including

exercise Maintain pulmonary function as close to normal

as possible Minimal (or no) side effects from medicine

Page 44: Asthma by Dr Sarma

Dr.Sarma@works 44

TOOL KIT WE HAVE

Relievers (Quick) Preventers (long term) Peak Flow meter Spirometry Patient education

Page 45: Asthma by Dr Sarma

Dr.Sarma@works 45

ASTHMA Rx. in INDIA TOADAY

Completely control symptoms and Make their life normal As good as abroad (even better) General practice physicians Doesn’t need Chest Physicians !

Page 46: Asthma by Dr Sarma

Dr.Sarma@works 46

IT IS A DUAL PROBLEM

1. Bronchial inflammation – perpetual1. Allergic inflammation and edema2. Inflammatory mediators – perpetuate3. edema and excite bronchospasm4. Bronchial hyper reactivity to triggers

2. Bronchospasm – acute attacks This needs two different types of

medicines – relievers & preventers

Page 47: Asthma by Dr Sarma

Dr.Sarma@works 47

WHAT ARE RELIEVERS ?

Spasm needs reliever Bronchodilator drugs Rescue medications Quick relief of symptoms Used during acute attacks Action lasts for 4-6 hrs Not for regular use at all

Page 48: Asthma by Dr Sarma

Dr.Sarma@works 48

RELIEVERS

Short acting 2 agonists - SABASalbutamol, TerbutalineLevo-salbutamol (Levolin)

Anti-cholinergicsIpatropium

Xanthines Theophylline (Deriphyllin group)

Page 49: Asthma by Dr Sarma

Dr.Sarma@works 49

Prevent future attacks Reduce allergic inflammation Reduce inflammatory mediators Reduce hyper-responsiveness Long term control of asthma Prevent airway remodeling For regular use – well or ill

WHAT ARE PREVENTERS ?

Page 50: Asthma by Dr Sarma

Dr.Sarma@works 50

PREVENTERS

Xanthines Theophylline SRMast cell stabilizersSodium cromoglycateNedocromil sodiumKetotifen, CeterizineCombinationsSalmeterol/FluticasoneFormoterol/BudesonideSalbutamol/Beclomethasone

CorticosteroidsPrednisolone, Betamethasone

Beclomethasone, Budesonide

Fluticasone

Long acting 2 agonists-LABABambuterol, Salmeterol

Formoterol, Bambuderol

Anti-leukotrienesMontelukast, Zafirlukast, Pranlukast

Page 51: Asthma by Dr Sarma

Dr.Sarma@works 51

CERTAIN ABBREVIATIONS

ICS Inhaled corticosteroids IBD Inhaled bronchodilators SABAShort acting βagonists LABA Long acting βagonists LTA Leukotrine antagonists OCS Oral corticosteroids SR Sustained release AchB Acetyl choline blockers

Page 52: Asthma by Dr Sarma

Dr.Sarma@works 52

NEW APPROACHES

Omalizumab injection Monoclonal antibody against Immunoglobin E (anti-IgE) Monoclonal antibody to block

the allergic antibody, IgE

Page 53: Asthma by Dr Sarma

Dr.Sarma@works 53

PLEASE REMEMBER

If our patient uses reliever medication every day, or even more than three or four times a week, preventer medication must be added to the treatment plan and reliever medication has to be with drawn.

GINA Workshop Report, December 2000

Page 54: Asthma by Dr Sarma

Dr.Sarma@works 54

Are we giving the right drug ?

Are we giving the drug in right form ?

Are we using the correct technique ?

LET US QUESTION

Page 55: Asthma by Dr Sarma

Dr.Sarma@works 55

WHAT HAPPENS WITH WRONG Rx. ?

N orm al

Inflam ed(Asthm a)

Partly Treated

F ixed O bstruction(Lead P ipe)

R em odelledA irw ay

Page 56: Asthma by Dr Sarma

Dr.Sarma@works 56

THE STORY OF ASTHMA TREATMENT

N orm al

R egularInha ledS teroid

PartlyTreated

Inflam ed (untreated)

Remodeled

Page 57: Asthma by Dr Sarma

Dr.Sarma@works 57

All Asthma drugs should ideally be

taken through the inhaled route.

MOST IMPORTANT

Page 58: Asthma by Dr Sarma

Dr.Sarma@works 58

WHAT CHANGES THEIR LIFE ?

ICS are the most potent and effective anti-inflammatory medication currently

available for Asthma *

*GINA (NHLBI & WHO Workshop Report), December 1995*Guidelines for the diagnosis and management of Asthma NIH,

NHLBI, May 1997

ICS

Inhaled corticosteroids

Page 59: Asthma by Dr Sarma

Dr.Sarma@works 59

Corticosteroids ??

Inhaled medicines ??

LET US BELIEVE FIRST

Patients’ wrong beliefParents / Grand parents

Neighbours / ‘friends’

First of all, let us believe in scienceLet us explain and convince themLet us change their lives – to happy lives

Page 60: Asthma by Dr Sarma

Dr.Sarma@works 60

Instead of asthma controlling our patient

REMEMBER

allow our patient to

control his / her asthma

Page 61: Asthma by Dr Sarma

Dr.Sarma@works 61

WHY INHALATION Rx.

Oral Slow onset of action Large dosage used Greater side effects Erratic absorption Not useful in acute

illness

Inhaled route Rapid onset of action Less amount of drug Drug delivered to

the site of mischief Better tolerated Treatment of choice

in acute symptoms

Page 62: Asthma by Dr Sarma

Dr.Sarma@works 62

PREVENTERS

Inhaled corticosteroids Budesonide/ beclomethasone/

fluticasone – use any Start (400-1000 mcg/day approx. in 2

divided doses) Maintain for 3 months Taper slowly and keep at 200 mcg Safe for long-term use (years)

Page 63: Asthma by Dr Sarma

Dr.Sarma@works 63

They are very safe Even in small children for several years 30% of Olympic athletes use ICS Not anabolic (performance-enhancing)

steroid Even highest ICS dose is safer than low

dose oral steroid or beta agonist Best “Addiction” for asthmatics

ICS – HOW SAFE ?

Page 64: Asthma by Dr Sarma

Dr.Sarma@works 64

ICS SAFE EVEN FOR A CHILD?

400 mcg/day (budesonide) Over 9 years of continuous use No growth retardation Uncontrolled asthma causes growth

retardation

Pedersen & Agertoft NEJM 2000

Page 65: Asthma by Dr Sarma

Dr.Sarma@works 65

PREGNANCY AND ASTHMA

Don’t x-ray (if possible) All asthma medication is safe Even oral corticosteroids are safe for

exacerbations Uncontrolled asthma during pregnancy

is a serious risk factor for foetal distress and anoxia

Thorax Supplement

Page 66: Asthma by Dr Sarma

Dr.Sarma@works 66

ICS not Effective ?

Check Inhaler Technique /Check Regular Use

Add LABAFormoterol / Salmeterol

Increase dose of inhaled steroid

Add Leukotriene modifier

Add SR Theophylline

Page 67: Asthma by Dr Sarma

Dr.Sarma@works 67

Step up and down - ACUTE SABA (IBD) in full doses SABA Increase frequency or Nebulize SABA as above + IPA (IBD), then add OCS (Prednisolone) 30-60 mg for 3 to 10 days - add ICS (1000 mcg) / day and maintain for 6 weeks minimum Gradually bring down doses and maintain with ICS If symptoms are not relieved – Check the technique and the compliance with Rx. Look for aggravating factors like

– GE Reflux, Emotions/ stress, Sinusitis– Allergic Rhinitis, Persistent allergens

No role for Theophylline; Oral SABA or LABA not very useful

Page 68: Asthma by Dr Sarma

Dr.Sarma@works 68

The Step Care Approach - Prevent

ICS ICS + LABA (IBD) ICS + LABA (IBD) + Double Dose ICS ICS (DD) + LABA + LTA (oral) ICS (DD) + LABA + LTA + OCS ICS (DD) + LABA + LTA + OCS + TIO (IBD) SR Theophylline may be add on SABA or LABA Oral + IPA (IBD) may be useful add on No long acting steroid injections No injectable or short acting Theophylline

Page 69: Asthma by Dr Sarma

Dr.Sarma@works 69

Leukotriene Modifiers

Oral leukotrine antagonist – anti inflammatoryNot as effective as inhaled steroidMay be first-line for 2 to 5 yr. olds.Montelukast available; Zafirlukast is not in India4 mg, 5 mg, 8 mg tabs availableCan be add on to ICS, IBD inhalers

Page 70: Asthma by Dr Sarma

Dr.Sarma@works 70

NOT ALL ARE SAME !!

Beclomethasone 6 hrly + Salbutamol 6th hrly Budesonide 12 hrly + Salmeterol 12 hrly Salmeterol 12 hrly + Ipatropium 12 hrly Fluticasone 24 hrly + Formoterol 24 hrly Formoterol 24 hrly + Tiotropium 24 hrlyChoice is based on1. If need is urgent and uncontrolled – 6 hrly2. If need is maintenance, well contr. – 12 hrly3. If stabilized and wants convenience – 24 hrly

Page 71: Asthma by Dr Sarma

Dr.Sarma@works 71

Formoterol + Budesonide combination - the Flexible Preventer

Ast

hma

sign

s

Time

2x2 2x2 1x11x21x2

Quicklygains control

Maintainscontrol

Asthmaworsening

Maintainscontrol

Reduce tolowest adequatedose that maintainscontrol

Page 72: Asthma by Dr Sarma

Dr.Sarma@works 72

Why doctors don’t use inhalation therapy

Status quo :“my practice is good or ‘great’”

Oral therapy is easyToo busyDifficulty in convincingCostHeadache to explain

Page 73: Asthma by Dr Sarma

Dr.Sarma@works 73

DRUG DELIVERY OPTIONS

Metered dose inhalers (MDI) Dry powder inhalers (Rotahaler) Spacers / Holding chambers Nebulizers

Page 74: Asthma by Dr Sarma

Dr.Sarma@works 74

Demonstration of the correct technique

Ask the patient to demonstrate to you the technique

Page 75: Asthma by Dr Sarma

Dr.Sarma@works 75

pMDI – Metered Dose Inhalers Rotahalers, Diskhalers Spacehalers Nebulizers Oxygen mixed delivery Oral tablets, syrups Parenteral – I.M or I.V use

1. Dexterity

2. Hand grip strength

3. Co-ordination

4. Severity of COPD

5. Educational level

6. Age of the patient

7. Ability to inhale and synchronize

DRUG DELIVERY - OPTIONS

Page 76: Asthma by Dr Sarma

Dr.Sarma@works 76

WHAT DRUG DELIVERY METHOD ?

Very young or very old MDI + LV Spacer Elderly MDI + SV spacer Young children > 7 yrs DPI (Rotahaler) Adults edu. understood MDI alone Adults no co-ordination DPI (Rotahalers) Clinic setting MDI + Spacer Clinic - emergency Nebulizer

Choice is to be individualizedTrial and error may be neededCost may be a factor

Page 77: Asthma by Dr Sarma

Dr.Sarma@works 77

DRUG DELIVERY - OPTIONS

Page 78: Asthma by Dr Sarma

Dr.Sarma@works 78

SpacerSpacehaler

RotahalerDry powder Inhaler

Metered dose inhaler or MDI

INHALATION DEVICES

Page 79: Asthma by Dr Sarma

Dr.Sarma@works 79

MDI + LARGE VOLUME SPACER

Page 80: Asthma by Dr Sarma

Dr.Sarma@works 80

ROTAHALER – DRY POWDER

Overcomes hand-lung coordination problems encountered with MDIs.

Can be easily used by children, elderly and arthritic patients.

Can take multiple inhalations if the entire drug has not been inhaled in one inhalation.

Page 81: Asthma by Dr Sarma

Dr.Sarma@works 81

THE ZEROSTAT ADVANTAGE

1. Non - static spacer made up of polyamide material2. Increased respirable fraction ® Increased deposition of

drug in the airways3. Increased aerosol half - life ® Plenty of time for the

patient to inhale after actuation of the drug4. No valve ® No dead space ® Less wastage of the drug5. Small, portable, easy to carry ® Child friendly

Page 82: Asthma by Dr Sarma

Dr.Sarma@works 82

DISKHALER – NEBULISER

Page 83: Asthma by Dr Sarma

Dr.Sarma@works 83

NEBULISED THERAPY

1. Severe breathlessness despite using inhalers 2. Assessment should be done for improvement3. Choice between a facemask or mouth piece4. Equipment servicing and support are essential5. Dosage 0.5 ml of Ipatropium +

0.5 ml of Salbutamol + 5 ml of NaCl (not DW)6. If decided to use ICS (FEV1 < 50%) –

0.5 ml of Budusonide is added to the above6. 15 minutes and slow or moderate flow rate7. Can be repeated 2 to 3 times a day – Mouth Wash

Page 84: Asthma by Dr Sarma

Dr.Sarma@works 84

PATIENT EDUCATION

Explain nature of the disease (inflammation) Explain action of prescribed drugs Stress the need for regular, long-term therapy That way only we can convince Allay fears and concerns Peak flow testing Symptom, treatment diary

Page 85: Asthma by Dr Sarma

Dr.Sarma@works 85

PATIENT EDUCATION

Asthma is a common disorder It can happen to anybody, May not be life long It is not caused by supernatural forces Asthma is not contagious, All kin needn’t be affected Recurrent attacks of cough with or without wheeze Between attacks people with asthma lead normal

lives as anyone else In most cases, there is some family history of allergy

Page 86: Asthma by Dr Sarma

Dr.Sarma@works 86

Asthma can be effectively controlled, although it cannot be cured.

Effective asthma management programs include education, objective measures of lung function, environmental control, and pharmacologic therapy.

A stepwise approach to pharmacologic therapy is recommended. The aim is to accomplish the goals of therapy with the least possible medication.

PATIENT EDUCATION

Page 87: Asthma by Dr Sarma

Dr.Sarma@works 87

A little time spent talkingto our patients - reallyis a great investment.

This may make all the differencebetween a happy life and pulmonary invalidity

YOURS FAITHFULLY REQUESTS

Page 88: Asthma by Dr Sarma

Dr.Sarma@works 88

Can We dare to make them pulmonary invalids ?LET US GIVE THEM

LIFE TIME HAPPINESS